MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Search

Fortrea Holdings Inc.

Geschlossen

BrancheGesundheitswesen

16.46 3.65

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

15.9

Max

17.14

Schlüsselkennzahlen

By Trading Economics

Einkommen

359M

-16M

Verkäufe

-9M

701M

EPS

0.12

Gewinnspanne

-2.267

Angestellte

14,500

EBITDA

341M

14M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

-5.43% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

781M

1.7B

Vorheriger Eröffnungskurs

12.81

Vorheriger Schlusskurs

16.46

Nachrichtenstimmung

By Acuity

50%

50%

159 / 361 Ranking in Healthcare

Fortrea Holdings Inc. Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

16. Jan. 2026, 23:29 UTC

Heiße Aktien

Stocks to Watch: Atossa Therapeutics, Union Pacific

16. Jan. 2026, 22:48 UTC

Akquisitionen, Fusionen, Übernahmen

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16. Jan. 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16. Jan. 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16. Jan. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

16. Jan. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Auto & Transport Roundup: Market Talk

16. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. Jan. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

16. Jan. 2026, 21:48 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16. Jan. 2026, 21:41 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16. Jan. 2026, 21:38 UTC

Akquisitionen, Fusionen, Übernahmen

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16. Jan. 2026, 20:44 UTC

Ergebnisse

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16. Jan. 2026, 20:42 UTC

Market Talk

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16. Jan. 2026, 20:28 UTC

Market Talk

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16. Jan. 2026, 19:12 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

16. Jan. 2026, 18:53 UTC

Market Talk

Global Crude Supply Enough to Absorb Any Iran Disruption -- Market Talk

16. Jan. 2026, 18:41 UTC

Market Talk

Netflix's Ad Business Seen as Primary Revenue Driver in 2026 -- Market Talk

16. Jan. 2026, 18:31 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 410 -- Market Talk

16. Jan. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

16. Jan. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. Jan. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

16. Jan. 2026, 17:03 UTC

Market Talk

Global Equities Roundup: Market Talk

16. Jan. 2026, 17:03 UTC

Market Talk

All Eyes on Guidance for European Big Pharma Earnings Season -- Market Talk

16. Jan. 2026, 16:32 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Sanofi Needs Dealmaking to Offset Pipeline Disappointments -- Market Talk

16. Jan. 2026, 16:20 UTC

Market Talk

Global Equities Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Fortrea Holdings Inc. Prognose

Kursziel

By TipRanks

-5.43% Nachteil

12-Monats-Prognose

Durchschnitt 15.86 USD  -5.43%

Hoch 25 USD

Tief 7 USD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Fortrea Holdings Inc. – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

9 ratings

4

Buy

4

Halten

1

Sell

Stimmung

By Acuity

159 / 361 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Fortrea Holdings Inc.

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
help-icon Live chat